Glibentek

glibenclamide

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Glibentek, covering 2025-09-08 to 2025-09-08. Get the full timeline:

Most recent: Clinical Trial Update: Glibentek in Patients With Neonatal Diabetes Secondary to Mutations in K+-ATP Channels [Phase 3]